Towards Healthcare

Top Companies

Your marketplace is evolving, your competitors are readjusting – but instead of reacting you can proact

Arthroscopy Devices Companies, Market Position Advancements, Strategic Resource Allocation, Cross-border Expansion & Patent Expansion

The arthroscopy devices companies are Arthrex, B. Braun, CONMED Corporation, DePuy Synthes, Endomed Systems, Fiegert Endotech, Karl Storz GmBH, Lepu Medical, Medtronic plc, Pioneer Healthcare Technologies, Richard Wolf, Smith & Nephew, Stryker Corporation, Wellcare Medical Systems and Zimmer Biomet.

28 November 2024

Newborn Screening Companies Innovation and Product Evolution, Operational Excellence, Strategic Joint Ventures, Financial Performance Evaluation & Future Market Positioning

The newborn screening companies are Bio-Rad Laboratories Inc., Agilent Technologies Inc., Natus Medical Inc., Waters, Siemens Healthineers AG, Bruker, GE HealthCare, Medtronic, Trivitron Healthcare and Masimo Corporation.

28 November 2024

Exosome Diagnostic and Therapeutic Companies | Corporate Milestones | Recent Strategic Partnerships | Cross-border Expansion

The exosome diagnostic and therapeutic market key players are Thermo Fisher Scientific Inc., Exosome Diagnostics, QIAGEN, System Biosciences LLC, ReNeuron, Hitachi Chemical Diagnostics Inc., Capricor Therapeutics Inc., Evox Therapeutics, Bio-Techne, Capital Biosciences Inc., Exogenus Therapeutics and Exo Biologics.

27 November 2024

Glutamine Top Manufacturers | Recent Developments | Operational Excellence | Patent Filing and Protection | Leadership and Governance

The glutamine key players are Kyowa Hakko Kirin Co., Ltd., Ajinomoto Co., Inc., Evonik Industries AG, Metabolic Technologies, Inc., Fufeng Group, Nutritech, Battery Nutrition Limited, Allmax Nutrition INC., Nutri Advanced Ltd and Optimum Nutrition.

27 November 2024

Atrial Fibrillation Treatment Companies-Recent Strategic Partnerships, Investment and Capital Allocation, IP Valuation, Leadership Alignment with Trends

The Atrial fibrillation treatment companies are Boston Scientific Corporation, Johnson & Johnson Med Tech, Pfizer, Bristol Myers Squibb, Boehringer Ingelheim Bayer, Novartis, AtriCure, Inc., Medtronic and Abbott.

27 November 2024

Cell Separation Technologies Companies | Technological Advancements | Value Creation | Cross-border Expansion | Patent Expansions | Market Trends Analysis

The cell separation technologies companies are Akadeum Life Sciences, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bristol Myers Squibb, Cellares, Duoning Biotechnology Group, Danaher Corporation, GE Healthcare, Merck, Miltenyi Biotec, STEMCELL Technologies, Terumo Corporation and Thermo Fisher Scientific.

26 November 2024

Upstream Bioprocessing Companies | Operational Enhancements | Competitive Positioning | Deal Structuring | Financial Performance Evaluation | Long-Term Forecasts

The upstream bioprocessing key players are Thermo Fisher Scientific, Inc., Merck KGaA, Corning Incorporated, Sartorius AG, Eppendorf AG, Danaher, Boehringer Ingelheim GmbH, Applikon Biotechnology, PBS Biotech, Inc., Lonza, VWR International, LLC, Meissner Filtration Products, Inc., Repligen Corporation, Entegris and Kuhner AG.

26 November 2024

Cervical Cancer Diagnostic Companies-Recent Strategic Partnerships, Competitive Positioning, Cross-border Expansion, Patent Expansions

The cervical cancer diagnostic companies are Abott Laboratories, Aptamer Group, plc, Becton, Dickinson and Company, Danaher Corporation, F. Hoffman-La Roche Ltd., Guided Therapeutics, Inc., Healthians Hologic, Inc., MobileODT Ltd, Novartis AG, Quest Diagnostics, Roche Diagnostics and Timser Group.

26 November 2024

Regenerative Medicine Companies-Corporate Milestones, Value Creation, Deal Structuring, Patent Expansions, Market Trends Analysis

The regenerative medicine key players are Medtronic, Stryker, Zimmer Biomet, Pfizer Inc, Novartis AG, Bristol-Myers Squibb, Vertex Pharmaceuticals Incorporated, Gamida Cell, Ferring B.V. and Syngene International Limited.

26 November 2024

Electronic Health Records Competitors-Recent Strategic Partnerships, Operational Enhancements, Revenue Diversification, Transaction Synergies

The electronic health records (EHR) companies are Epic Systems Corporation, Allscripts Healthcare Solutions, Inc., McKesson Corporation, GE Healthcare, NextGen Healthcare, Inc., Athenahealth, OpenEMR, Siemens Healthineers AG, eClinicalWorks and Medical Information Technology, Inc.

26 November 2024

Showing 441 to 450 of 455 companies